The Jefferies Group LLC Trims Walgreens Boots Alliance Inc (WBA) Target Price to $80.00

The Jefferies Group LLC Trims Walgreens Boots Alliance Inc (WBA) Target Price to $80.00

Other equities analysts have also recently issued reports about the company. Guggenheim reaffirmed a buy rating and issued a $100.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, April 6th. Deutsche Bank AG reaffirmed a buy rating and issued a $92.00 price target on shares of Walgreens Boots Alliance in a research note on Tuesday, January 31st. Evercore ISI reaffirmed a buy rating and issued a $93.00 price target on shares of Walgreens Boots Alliance in a research note on Tuesday, January 31st. Leerink Swann set a $90.00 price target on Walgreens Boots Alliance and gave the stock a buy rating in a research note on Tuesday, April 11th. Finally, Zacks Investment Research raised Walgreens Boots Alliance from a sell rating to a hold rating in a research note on Thursday, March 23rd. One analyst has rated the stock with a sell rating, four have given a hold rating and eleven have given a buy rating to the stock. The company currently has a consensus rating of Buy and an average target price of $90.62.

Walgreens Boots Alliance Inc (NASDAQ:WBA) had its price objective trimmed by Jefferies Group LLC from $95.00 to $80.00 in a research note issued to investors on Wednesday. The firm currently has a buy rating on the pharmacy operator’s stock.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) opened at 83.10 on Wednesday. The company has a market capitalization of $89.83 billion, a PE ratio of 21.36 and a beta of 1.20. Walgreens Boots Alliance has a one year low of $76.26 and a one year high of $89.69. The company has a 50-day moving average price of $83.80 and a 200 day moving average price of $83.97. Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, April 5th. The pharmacy operator reported $1.36 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.36. The business had revenue of $29.45 billion for the quarter, compared to analysts’ expectations of $30.17 billion. Walgreens Boots Alliance had a return on equity of 16.76% and a net margin of 3.52%. The business’s quarterly revenue was down 2.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.31 EPS. Equities analysts anticipate that Walgreens Boots Alliance will post $4.97 EPS for the current year.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) opened at 83.10 on Wednesday. The company has a market capitalization of $89.83 billion, a PE ratio of 21.36 and a beta of 1.20. Walgreens Boots Alliance has a one year low of $76.26 and a one year high of $89.69. The company has a 50-day moving average price of $83.80 and a 200 day moving average price of $83.97. The firm also recently declared a quarterly dividend, which will be paid on Monday, June 12th. Stockholders of record on Thursday, May 18th will be paid a $0.375 dividend. This represents a $1.50 annualized dividend and a dividend yield of 1.81%. The ex-dividend date of this dividend is Tuesday, May 16th. Walgreens Boots Alliance’s dividend payout ratio is currently 39.68%.

In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Wednesday, May 3rd. The stock was sold at an average price of $85.89, for a total value of $234,995.04. Following the completion of the transaction, the director now owns 21,887 shares in the company, valued at $1,879,874.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 13.50% of the stock is owned by insiders. Several hedge funds and other institutional investors have recently bought and sold shares of WBA. Hudock Capital Group LLC boosted its position in Walgreens Boots Alliance by 0.4% in the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $108,000 after buying an additional 5 shares in the last quarter. Modera Wealth Management LLC boosted its position in Walgreens Boots Alliance by 0.4% in the first quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock valued at $204,000 after buying an additional 9 shares in the last quarter. Flagship Harbor Advisors LLC boosted its position in Walgreens Boots Alliance by 0.5% in the first quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock valued at $243,000 after buying an additional 16 shares in the last quarter. Sowell Financial Services LLC boosted its position in Walgreens Boots Alliance by 0.6% in the first quarter. Sowell Financial Services LLC now owns 2,703 shares of the pharmacy operator’s stock valued at $218,000 after buying an additional 17 shares in the last quarter. Finally, Glassman Wealth Services boosted its position in Walgreens Boots Alliance by 0.6% in the fourth quarter. Glassman Wealth Services now owns 2,898 shares of the pharmacy operator’s stock valued at $240,000 after buying an additional 18 shares in the last quarter. Hedge funds and other institutional investors own 59.98% of the company’s stock.

Walgreens Boots Alliance Company Profile Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:WBA”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Walgreens Boots Alliance Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment